Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...

Myasthenia gravis (MG) is a rare autoimmune disease that can impact vision, speech, mobility, and breathing, but treatments ...

Andrea Divis was shocked to learn that her symptoms of fatigue, blurred vision, and muscle weakness were due to a rare condition called myasthenia gravis. Here’s how she educated herself and took back ...

Findings showed gefurulimab statistically significantly improved MG-ADL total score at week 26 compared with placebo. Topline data were announced from a phase 3 trial evaluating gefurulimab in adults ...

Myasthenia gravis (MG) is a rare autoimmune neuromuscular disorder that causes fluctuating muscle weakness, often affecting daily activities like speaking, walking, or even breathing. While symptoms ...

WASHINGTON — Monica Seles first noticed the symptoms of myasthenia gravis — a neuromuscular autoimmune disease she discussed during a recent interview with The Associated Press — while she was ...

Positive topline results from two phase 3 trials reported this week may expand the treatment landscape for generalized myasthenia gravis (gMG), a rare autoimmune disease marked by debilitating muscle ...

Credit: Johnson & Johnson. Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG ...